ArteFill: a permanent skin filler. [2006.05]
Adapalene gel, 0.1%, as maintenance therapy for acne vulgaris: a randomized, controlled, investigator-blind follow-up of a recent combination study. [2006.05]
A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomized, physician-blinded, split-face comparative trial. [2006.05]
A clinical retrospective study comparing two short-scar face lifts: minimal access cranial suspension versus lateral SMASectomy. [2006.04.15]
The effect of Cetaphil Gentle Skin Cleanser on the skin barrier of patients with rosacea. [2006.04]
Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens. [2006.04]
Split-face comparison of radiofrequency versus long-pulse Nd-YAG treatment of facial laxity. [2006.04]
Red light-emitting diode (LED) therapy accelerates wound healing post-blepharoplasty and periocular laser ablative resurfacing. [2006.04]
Photodynamic therapy of acne vulgaris using 5-aminolevulinic acid versus methyl aminolevulinate. [2006.04]
Metronidazole in the treatment of rosacea: do formulation, dosing, and concentration matter? [2006.04]
Low- and high-dose botulinum toxin A treatment: a retrospective analysis. [2006.04]
Laser skin resurfacing with a novel portable erbium:YAG laser. [2006.04]
Efficacy and safety of once-daily metronidazole 1% gel compared with twice-daily azelaic acid 15% gel in the treatment of rosacea. [2006.04]
Clinical and instrumental evaluation of skin improvement after treatment with a new 50% pyruvic acid peel. [2006.04]
A novel aqueous metronidazole 1% gel with hydrosolubilizing agents (HSA-3). [2006.04]
A look at the safety of metronidazole 1% gel: cumulative irritation, contact sensitization, phototoxicity, and photoallergy potential. [2006.04]
A comparison study of the efficacy and side effects of different light sources in hair removal. [2006.04]
[Temporal three-point relief-tension suspension technique for facial rhytidectomy] [2006.03]
[Photodynamic therapy in dermatology] [2006.03]
Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial. [2006.03]
Sunscreens with an absorption maximum of > or =360 nm provide optimal protection against UVA1-induced expression of matrix metalloproteinase-1, interleukin-1, and interleukin-6 in human dermal fibroblasts. [2006.03]
Safety of radiofrequency treatment over human skin previously injected with medium-term injectable soft-tissue augmentation materials: a controlled pilot trial. [2006.03]
Repeated treatment protocols for melasma and acquired dermal melanocytosis. [2006.03]
Prevention of UV radiation-induced premature skin aging in hairless mice by the novel compound Melanocin A. [2006.03]
Patient satisfaction and reported long-term therapeutic efficacy associated with 1,320 nm Nd:YAG laser treatment of acne scarring and photoaging. [2006.03]
Intense pulsed light treatment of 1,000 consecutive patients with facial vascular marks. [2006.03]
Efficacy and safety of 3- and 5-injection patterns (30 and 50 U) of botulinum toxin A (Dysport) for the treatment of wrinkles in the glabella and the central forehead region. [2006.03]
Effects of isotretinoin on the metabolism of triglyceride-rich lipoproteins and on the lipid profile in patients with acne. [2006.03]
Effect of monopolar radiofrequency treatment over soft-tissue fillers in an animal model: part 2. [2006.03]
Effect of a single overnight topical application of miconazole nitrate paste on acne papules. [2006.03]
Diplopia associated with the cosmetic use of botulinum toxin a for facial rejuvenation. [2006.03]
Development and evaluation of sesamol as an antiaging agent. [2006.03]
Cutaneous sarcoidal granulomas developing after Artecoll facial cosmetic filler in a patient with newly diagnosed systemic sarcoidosis. [2006.03]
Consensus recommendations for soft-tissue augmentation with nonanimal stabilized hyaluronic acid (Restylane). [2006.03]
Community-based trial of a triple-combination agent for the treatment of facial melasma. [2006.03]
An update on the role of topical metronidazole in rosacea. [2006.03]
A pilot study on efficacy treatment of acne vulgaris using a new method: results of a randomized double-blind trial with Acne Dressing. [2006.03]
Green tea polyphenol epigallocatechin-3-gallate inhibits the expression of nitric oxide synthase and generation of nitric oxide induced by ultraviolet B in HaCaT cells. [2006.02.20]
Kinetics of membrane raft formation: fatty acid domains in stratum corneum lipid models. [2006.02.09]
The effect of 2',4',7-trihydroxyisoflavone on ultraviolet-induced matrix metalloproteinases-1 expression in human skin fibroblasts. [2006.02.06]
Treatment of inflammatory facial acne with the 1,450 nm diode laser alone versus microdermabrasion plus the 1,450 nm laser: a randomized, split-face trial. [2006.02]
Treatment of hyperpigmentation-melasma with photodynamic therapy. [2006.02]
The use of topical azelaic acid for common skin disorders other than inflammatory rosacea. [2006.02]
The use of photodynamic therapy in dermatology: results of a consensus conference. [2006.02]
The evolution of azelaic acid. [2006.02]
Targeting matrix metalloproteases to improve cutaneous wound healing. [2006.02]
Split treatment of photodamaged skin with KTP 532 nm laser with 10 mm handpiece versus IPL: a cheek-to-cheek comparison. [2006.02]
Skin surface topography grading is a valid measure of skin photoaging. [2006.02]
Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. [2006.02]
Photodynamic therapy for the treatment of erythema, papules, pustules, and severe flushing consistent with rosacea. [2006.02]
<< Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next >>
